The Board of Directors oversees the business of Cancer Council SA, the business name of the Anti-Cancer Foundation of South Australia (the ‘Company’).
The Board’s key objectives are to:
- Set the strategic directions for Cancer Council SA and effective oversight of management.
- Optimise Cancer Council SA's performance and stakeholder value within a framework of appropriate risk assessment and management.
- Recognise Cancer Council SA's legal and other obligations to all legitimate stakeholders.
To achieve these objectives, the Board is committed to working towards best corporate governance practices.
Corporate governance is concerned with the way that the Directors ensure that the organisation’s systems and processes are properly controlled and functioning effectively and that management is complying with the Board's policies and directives.
To assist the Board to meet their statutory and fiduciary obligations, it is supported by four board committees. The role of each committee is outlined below.
Nomination and Remuneration Committee
- Reviews and make recommendations to the Board on the structure of remuneration packages and policies applicable to the Chief Executive, senior executives and staff. The Board utilises a company-wide process for determining remuneration. The services of an external remuneration consultant are used to conduct benchmarking.
- Reviews remuneration policy and compliance with approved policy.
- Monitors succession planning and development, company culture and implementation of and compliance with the Organisation Development Policy.
- Monitors and reviews the composition of the Board, recommends nominations to the Board, and manages the Director and Board performance evaluation process.
Audit and Risk Committee
The primary responsibility of the Committee is to assist the Board of Directors in fulfilling its responsibilities in relation to the identification of areas of significant business risks and the monitoring of:
- Effective management of financial business risks
- Reliable management reporting
- Compliance with laws and regulations in respect to financial reporting
- Maintenance of an effective and efficient audit
- Related party transactions
- The protection of physical and financial assets.
The role of the Investment Committee is to recommend investment policy, review the appointment and performance of fund managers, monitor compliance with investment policy and monitor risk control limits.
Management of Investments
Cancer Council SA maintains a diversified portfolio in accordance with its Investment policy. Available for sales assets are held with Macquarie Private Wealth, Warakirri Asset Management, Nikko Asset Management Limited and Maple Brown Abbott Limited, Australia and New Zealand Banking Group Limited and Commonwealth Bank of Australia
Cancer Research Committee
The role of the Cancer Research Committee is to support the strategic research targets of Cancer Council SA by monitoring and assessing investments in cancer research and making recommendations to the Board on funding options.
Conflict of interest
There is an expectation in the community that the Boards of organisations like Cancer Council SA will operate in a transparent manner using best practice standards for corporate governance.
The Board recognises that proactive management of actual conflicts of interest will significantly reduce legal risks for individual Board members and the Board as a whole. Inadequate management of perceived conflicts of interest may damage the reputation and effectiveness of individual Board members, the Board and Cancer Council SA.
Therefore the Board has implemented a systematic and transparent process for dealing appropriately with each case. The Board recognises that it is not possible to eliminate every possible conflict of interest that may arise and have affect on Board and Board committee members.
The Cancer Council SA’s Risk Management philosophy is as much about grasping opportunities and creating successes as it is about minimising losses. Risk is therefore as much about something good not happening as something bad happening. The goal is not to eliminate all risk but rather to ensure that risk is maintained at an acceptable level in a cost effective manner.
Risk Management requires:
- forward thinking and a pro-active approach to management
- achieving a balance between the costs of managing risk and the anticipated benefits and
- using a formal systematic approach of identifying, analysing, evaluating, treating, monitoring and communicating risks associated with any activity, function or process.
This will facilitate decision making, ensure good governance through the performance and accountability of all employees and will also assist to ensure resources are properly allocated to manage those risks.
Cancer Council SA is committed to the management of all types of risks within its operations to assist in the achievement of its goals, programs, targets and its vision as outlined in the Strategic Management Plan.
Cancer Council SA will maintain risk management practices that provide it with a consistent, systematic view of the risk it faces in the course of its activities. These practices will be consistent with the guidelines and principles of risk management as set out in the Australian Risk Management Standard ISO 31000:2009 and business best practice.
Cancer Council SA’s Risk Management Framework and Methodology supports this Policy and will provide a formal, systematic approach to risk management which is consistent with the guidelines and principles of the Risk Management Standard.
Please view our Board of Director profiles below.
Rear Admiral The Honourable Kevin Scarce AC CSC RANR Rtd
- 1 November 2014
Chairman, Nomination and Remuneration
Committee Member, Investment Committee
Chairman Kevin Scarce was born in Adelaide, educated at Elizabeth East Primary School and Elizabeth High School, before joining the Royal Australian Navy in 1968.
One of Kevin’s first postings at sea was on HMAS Sydney in Vietnam. In between his many and increasingly senior postings, Kevin completed a Bachelor of Financial Administration Degree (1998), a Master of Management Economics Degree at the University of NSW, ADFA campus (1990) and a Master’s Degree in National Security Strategy at the War College, US National Defense University in Washington DC (1994). In his last appointment in the Australian Defence Force, Kevin temporarily led the Defence Materiel Organisation.
Following retirement, Kevin formed and led the South Australian Government team charged with expanding the State’s defence business opportunities. One of the team’s first initiatives, to build air warfare destroyers in Adelaide, was successfully achieved in May 2005 when the Federal Government awarded the contract to a locally-based company. In 2006 Kevin became an advisor and Board member of the Port Adelaide Maritime Corporation, formed to establish the state’s shipbuilding infrastructure and associated skills base. He was also Chairman of the Board of Foundation Daw Park, which generates funding for medical research for veterans and older Australians.
Kevin is also the Chair of the Adelaide Oval Stadium Management Authority. Kevin was sworn in as the 34th Governor of South Australia on 8 August 2007, serving more than seven years in the Vice-Regal role. Kevin was awarded the Conspicuous Service Cross in 1994 and appointed an Officer in the Military Division of the Order of Australia in 2004 and a Companion in the General Division of the Order of Australia in 2008 for his service to Australia’s defence industry and to the people of South Australia. In December 2009, Flinders University and the University of New England have both bestowed an Honorary Doctorate in recognition of his distinguished service to the nation and to the public of South Australia.
Mr Jim Birch AM, BHA, FACHSM, AAICA
- 30 November 2012
Chairman, Cancer Research Committee
Member, Strategic Fundraising Committee
Member, Nomination and Remuneration Committee
Director Jim Birch is currently an independent consultant and Non Executive Director of a number of Boards. He was formerly Ernst & Young’s Global Health Leader and Government and Public Sector Leader, Oceania. Jim has been Chief Executive of the Human Services and Health Department (South Australia), Deputy Chief Executive of Justice, and Chief Executive of major health service delivery organisations, including teaching hospitals. Jim is currently Deputy Chair of the Independent Hospital Pricing Authority, Chair of the Australian Red Cross Blood Service, Chair of the Australian Digital Health Agency, a member of the Board of the Australian Red Cross Society, Chair of Clevertar Pty Ltd, a member of the Board of the Little Company of Mary Health Care and Chair of the Women and Children’s Local Health Network (SA) Taskforce.
Mr Greg Boulton AM BA (Accountancy) FCA, FCPA, FAICD
- 13 February 2015
- Deputy Chairman - appointed 19 February 2018
Chairman, Audit and Risk Committee
Chairman, Strategic Fundraising Committee
Member, Nomination and Remuneration Committee (appointed 19/2/2018)
Deputy Chairman Greg Boulton is a Fellow of the Institute of Chartered Accountants, CPA Australia and the Australian Institute of Company Directors. Greg was Managing Director of IPEC Transport for seven years. After 20 years’ experience in senior management roles, he consulted on change management implementation, strategic planning, best practice programs and transport. He is on the Board of a number of private and public companies and has broad experience in capital raising, acquisitions and commercial negotiations and management. Greg is also on the Boards of Statewide Superannuation Fund, Kangaroo Island Plantation Timbers Limited and Southern Gold Ltd. He was also President of the Port Adelaide Football Club from 1992 to 2008.
The Hon Catherine Branson AC QC BA LLB (Adel) Hon LLD (Flin) Hon D Litt (Macq)
- 25 March 2015
Director Catherine Branson is a former Judge of the Federal Court of Australia and a past President of the Australian Human Rights Commission. Earlier in her career she held the positions of Crown Solicitor of South Australia and CEO of the Attorney-General’s Department (SA) before leaving public employment to practise as a Barrister. Catherine is presently Deputy Chancellor of The University of Adelaide, an Adjunct Professor of the Adelaide Law School and a Fellow of the Australian Academy of Law. She Chairs the Board of the Human Rights Law Centre. Throughout her career she has served in a voluntary capacity on the governance or advisory bodies of a significant number of organisations and charities involved with the arts, health, education or human rights.
Mr Con Michalakis BSc(Ma) MSc
- 24 March 2011
Chairman, Investment Committee
Director Con Michalakis is responsible for managing Statewide Super’s $8 billion in funds under management. Prior to joining Statewide, Con was Director of Marketing and Client Services for Manhattan-based boutique investment firm Pzena Investment Management, where he was responsible for marketing the
firm’s products and services in Australia, New Zealand, Hong Kong and Singapore. He was previously the Director, Head of Institutional Business, for Merrill Lynch Investment Managers based in Sydney. Con has also worked in London with Alliance Capital Management and was the first Australian practice leader of investment consulting for Watson Wyatt. Con has a Bachelor of Mathematical Science from the University of Adelaide, a Masters of Science from the University of London and a Postgraduate Diploma in Financial Strategy from Saïd Business School at the University of Oxford.
Professor David Watson MBBS, MD, FRACS, FAHMS
- 14 October 2015
Member, Cancer Research Committee
Member, Strategic Fundraising Committee
Since 2002, Director Professor David Watson has been Head of the Flinders University Department of Surgery and is an Oesophageal and Gastric Surgeon at Flinders Medical Centre. Before joining Flinders University, he worked as a Consultant Surgeon at the Royal Adelaide Hospital for nine years. He also leads research groups at Flinders University to improve early detection and prevention of gastrointestinal cancer, has published more than 400 research papers and textbook chapters, and has held continuous funding from the National Health and Medical Research Council for more than 20 years. He led the development of clinical guidelines for the management and prevention of oesophageal cancer for Cancer Council Australia.
David is a Senior Editor of the ANZ Journal of Surgery, and Associate Editor of the World Journal of Surgery, and a member of the Editorial Boards for many other leading international journals including the British Journal of Surgery and the Journal of Gastrointestinal Surgery. In 2006, David led the establishment of the Australia and New Zealand Gastric and Oesophageal Surgery Association, and he served as the foundation President until 2010. He currently serves as the Vice-President for the International Society for Diseases of the Esophagus, and serves on the National Council for the Australian Academy of Health and Medical Sciences. He is a recipient of the Royal Australasian College of Surgeons’John Mitchell Crouch Fellowship, a James IV Travelling Fellowship, was elected to Fellowship
of the Australian Academy of Health and Medical Sciences, and appointed to a Matthew Flinders Distinguished Professorship at Flinders University.
Jennifer Richter, GAICD, FACHSM, FACN, MBA, GradDipHAdmin, BA(Comms)
- 16 October 2019
Member, Audit and Risk Committee
Member, Investment Committee
Jenny Richter is currently an independent consultant and a Non-Executive Director on a number of Boards.
Jenny’s previous executive roles include Deputy Chief Executive for SA Health, a position she held for five years and more recently as CEO of Central Adelaide Local Health Network.
Jenny’s experience in the health sector commenced as a Registered Nurse. Throughout her careers she has gained significant leadership experience as an administrator and executive in the public and private hospital sectors, within community nursing, in the private financing sector through public private partnership projects and within the SA public health system.
Before joining SA Health, Jenny was an Executive Director with the Plenary Group advising on health service planning and infrastructure projects. This included working with Plenary Group on the Victorian Comprehensive Cancer Centre. Jenny also has significant experience in areas of hospital and health service and facility planning and health service performance, both in Australia and the UK.
Jenny is a graduate of the Australian Institute of Company Directors, a Fellow of the Australasian College of Heath Service Management and a Fellow of the Royal College of Nursing Australia. She has a Master of Business Administration, a Grad Dip in Health Administration and a Bachelor of Arts.
Jenny currently holds directorships with the South Australian Health & Medical Research Institute and the Southern Adelaide Local Health Network where she also chairs the Clinical Governance Board Sub-Committee.